1. Home
  2. ATYR vs HAIN Comparison

ATYR vs HAIN Comparison

Compare ATYR & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • HAIN
  • Stock Information
  • Founded
  • ATYR 2005
  • HAIN 1993
  • Country
  • ATYR United States
  • HAIN United States
  • Employees
  • ATYR N/A
  • HAIN N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • HAIN Packaged Foods
  • Sector
  • ATYR Health Care
  • HAIN Consumer Staples
  • Exchange
  • ATYR Nasdaq
  • HAIN Nasdaq
  • Market Cap
  • ATYR 290.6M
  • HAIN 265.3M
  • IPO Year
  • ATYR 2015
  • HAIN 1993
  • Fundamental
  • Price
  • ATYR $3.30
  • HAIN $1.58
  • Analyst Decision
  • ATYR Strong Buy
  • HAIN Hold
  • Analyst Count
  • ATYR 6
  • HAIN 9
  • Target Price
  • ATYR $18.60
  • HAIN $5.00
  • AVG Volume (30 Days)
  • ATYR 1.1M
  • HAIN 3.7M
  • Earning Date
  • ATYR 05-07-2025
  • HAIN 05-07-2025
  • Dividend Yield
  • ATYR N/A
  • HAIN N/A
  • EPS Growth
  • ATYR N/A
  • HAIN N/A
  • EPS
  • ATYR N/A
  • HAIN N/A
  • Revenue
  • ATYR N/A
  • HAIN $1,615,231,000.00
  • Revenue This Year
  • ATYR $551.06
  • HAIN N/A
  • Revenue Next Year
  • ATYR $2,144.84
  • HAIN $1.56
  • P/E Ratio
  • ATYR N/A
  • HAIN N/A
  • Revenue Growth
  • ATYR N/A
  • HAIN N/A
  • 52 Week Low
  • ATYR $1.42
  • HAIN $1.30
  • 52 Week High
  • ATYR $4.66
  • HAIN $9.43
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 52.29
  • HAIN 22.93
  • Support Level
  • ATYR $3.06
  • HAIN $1.30
  • Resistance Level
  • ATYR $3.45
  • HAIN $3.07
  • Average True Range (ATR)
  • ATYR 0.24
  • HAIN 0.23
  • MACD
  • ATYR 0.01
  • HAIN -0.13
  • Stochastic Oscillator
  • ATYR 52.46
  • HAIN 14.89

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: